AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Other Stockholders Equity · Q3 FY2025 · quarter ended Sep 2025

Other stockholders equity of €12.46M in Q3 FY2025

Q3 FY2025 other stockholders equity was €12.46M.

Context

  • Other stockholders equity amounted to 7.5% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€12.46M— QoQ
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

Currency unavailable · from the balance sheet

No Other Stockholders Equity data reported for this period type.

Other Stockholders Equity vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so other stockholders equity is compared through growth and share of total assets rather than absolute size.
  • Other stockholders equity amounts to 7.5% of total assets for AGMB, versus a peer median of 0.0%.
AGMB Competitors
Other Stockholders Equity for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€12.46M EUR——7.5%
ANABAnaptysBio, Inc.Mar 2026$0 USD——0.0%
ALMSAlumis Inc. Common StockJun 2026$0 USD——0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD——0.0%
EQEquillium, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) ———0.0%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.